Arrayit Corporation Announces Global Expansion of Finger Stick Finger Stick Health and Wellness Services – Other Nonprescription Drugs: ARYC



[ad_1]

Sunnyvale, July 29, 2019 (GLOBE NEWSWIRE) – Arrayit Corporation (OTC: ARYC), a Life Sciences and Personalized Medicine Company, Announces Expansion of Health Care Testing Services international clientele in the Philippines, who now have access to the practical functions of the company. testing services prescribed by a physician for food sensitivity and intolerance. Arrayit sampling and collection of blood maps, combined with highly automated tests and digital test reports, provide a seamless solution for Filipino physicians who use Arrayit test results to adjust their patients' regimens to improve their health and well-being. Working closely with a leading Filipino healthcare company, Arrayit Health and Wellness Services is now available to more than 100 million people (100 million) in Southeast Asia expanding and the twelfth largest country in the world. The 1.7 million inhabitants of the nation's capital Manila reside in the most densely populated city in the world.

Arrayit has recently completed a pilot allergy testing program for a large distribution chain, established a national network of 1,700 allergy sales professionals, met with the highest officials of the Food and Drug Administration (FDA). ) in the United States regarding the approval of a large line of products, clinical instrumentation contract, endorsement of in-store promotions by a large retailer, announcement of partnerships in the field of drug testing. allergy with major allergy treatment providers, approval of direct billing to Medicare and Medicare electronic reimbursement from the Centers for Medicare and Medicaid services, launch of Patient Data Solutions The Allergy Portal for Doctors and Patients clinics, celebrating 25 years of operating the company, announced the signing of an allergy testing services agreement with a leading supplier of ins health and welfare, sent a letter to the shareholders of the CEO of the company. Allergy testing network services has spent two million dollars a week, has appointed a partner of Apple's health sector to accelerate revenue and earnings growth, expanded the evaluation of testing services of 'allergy with a large chain of pharmacies, has developed its allergy test the health care network in more than 700 clinics, retain the services of a recognized business to accelerate repayment of the commercial and government payer, participate in five rounds of consecutive skills tests with a leader in skill testing, sign a network allergy testing services contract with a large Washington-based health protection company provider, received a certificate of presumed status until 2020 from the California Department of Public Health and expanded its network of clinics in Hawaii. Income and test results in the Philippines will be disclosed in the company's next quarterly and annual audited financial statements.

Rene Schena, CEO, says, "The global expansion of our health and wellness testing services in the Philippines is part of our mission to make health care more accessible internationally. With universal health coverage and rising living standards, the Philippines offers a tremendous growth opportunity for Arrayit and its shareholders as we expand into Southeast Asia and beyond. "

About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, Calif., Leads and empowers the biotech, pharmacy, clinical and healthcare sectors by discovering, developing and manufacturing exclusive life sciences products and services and personalized medicine to advance biomedical research and improve human health and well-being. Please visit www.arrayit.com for more information.

Declaration of the Safe Harbor
We have identified forward-looking statements using terms such as "expect", "believe", "we would". While we believe our expectations are reasonable, our business involves a number of risks and uncertainties beyond our control. The risk factors badociated with our business, including some of the facts set out herein, are described in detail in the Company's filings.

CONTACT
Investor Relations
Arrayit Company
Phone: 408-744-1331
Email: [email protected]
Web: www.arrayit.com

Investor Relations
Arrayit Company
Phone: 408-744-1331
Email: [email protected]
Web: www.arrayit.com
[ad_2]
Source link